nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—type 2 diabetes mellitus—polycystic ovary syndrome	0.653	1	CtDrD
Losartan—ACE—polycystic ovary syndrome	0.211	1	CbGaD
Losartan—ACE—tunica intima—polycystic ovary syndrome	0.00397	0.0947	CbGeAlD
Losartan—UGT2B17—endometrium—polycystic ovary syndrome	0.00369	0.0879	CbGeAlD
Losartan—UGT1A1—urine—polycystic ovary syndrome	0.00303	0.0723	CbGeAlD
Losartan—UGT2B17—endocrine gland—polycystic ovary syndrome	0.00259	0.0616	CbGeAlD
Losartan—ACE—urine—polycystic ovary syndrome	0.00195	0.0466	CbGeAlD
Losartan—Epigastric discomfort—Metformin—polycystic ovary syndrome	0.00175	0.0623	CcSEcCtD
Losartan—CYP2C19—urine—polycystic ovary syndrome	0.00164	0.0392	CbGeAlD
Losartan—Toothache—Metformin—polycystic ovary syndrome	0.00151	0.0538	CcSEcCtD
Losartan—UGT1A10—endocrine gland—polycystic ovary syndrome	0.00146	0.0348	CbGeAlD
Losartan—Respiratory distress—Metformin—polycystic ovary syndrome	0.00145	0.0515	CcSEcCtD
Losartan—CYP1A2—urine—polycystic ovary syndrome	0.00134	0.032	CbGeAlD
Losartan—SLC2A9—adrenal gland—polycystic ovary syndrome	0.00132	0.0315	CbGeAlD
Losartan—CYP2C9—urine—polycystic ovary syndrome	0.00127	0.0304	CbGeAlD
Losartan—SLC2A9—female gonad—polycystic ovary syndrome	0.00123	0.0293	CbGeAlD
Losartan—SLC2A9—endocrine gland—polycystic ovary syndrome	0.00114	0.0273	CbGeAlD
Losartan—UGT1A3—endocrine gland—polycystic ovary syndrome	0.00103	0.0245	CbGeAlD
Losartan—CYP3A4—urine—polycystic ovary syndrome	0.000971	0.0232	CbGeAlD
Losartan—SLCO1B3—pituitary gland—polycystic ovary syndrome	0.000934	0.0223	CbGeAlD
Losartan—SLCO1B3—vagina—polycystic ovary syndrome	0.000773	0.0184	CbGeAlD
Losartan—Nasal congestion—Metformin—polycystic ovary syndrome	0.000733	0.0261	CcSEcCtD
Losartan—Injury—Metformin—polycystic ovary syndrome	0.000727	0.0259	CcSEcCtD
Losartan—SLCO1B3—endocrine gland—polycystic ovary syndrome	0.000723	0.0172	CbGeAlD
Losartan—Renal impairment—Metformin—polycystic ovary syndrome	0.000702	0.025	CcSEcCtD
Losartan—AGTR1—adrenal cortex—polycystic ovary syndrome	0.000701	0.0167	CbGeAlD
Losartan—Hypoglycaemia—Metformin—polycystic ovary syndrome	0.000684	0.0244	CcSEcCtD
Losartan—Pain in extremity—Metformin—polycystic ovary syndrome	0.000668	0.0238	CcSEcCtD
Losartan—Migraine—Metformin—polycystic ovary syndrome	0.000657	0.0234	CcSEcCtD
Losartan—ACE—embryo—polycystic ovary syndrome	0.000631	0.0151	CbGeAlD
Losartan—Breast disorder—Metformin—polycystic ovary syndrome	0.000604	0.0215	CcSEcCtD
Losartan—Cramp muscle—Metformin—polycystic ovary syndrome	0.000601	0.0214	CcSEcCtD
Losartan—UGT2B7—endocrine gland—polycystic ovary syndrome	0.000591	0.0141	CbGeAlD
Losartan—Influenza—Metformin—polycystic ovary syndrome	0.000577	0.0205	CcSEcCtD
Losartan—AGTR1—pituitary gland—polycystic ovary syndrome	0.000566	0.0135	CbGeAlD
Losartan—Pancreatitis—Metformin—polycystic ovary syndrome	0.000566	0.0201	CcSEcCtD
Losartan—AGTR1—adipose tissue—polycystic ovary syndrome	0.000564	0.0134	CbGeAlD
Losartan—Angina pectoris—Metformin—polycystic ovary syndrome	0.000562	0.02	CcSEcCtD
Losartan—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.000537	0.0191	CcSEcCtD
Losartan—AGTR1—adrenal gland—polycystic ovary syndrome	0.000506	0.0121	CbGeAlD
Losartan—Neuropathy peripheral—Metformin—polycystic ovary syndrome	0.000505	0.018	CcSEcCtD
Losartan—UGT1A1—endocrine gland—polycystic ovary syndrome	0.000503	0.012	CbGeAlD
Losartan—AGTR1—vagina—polycystic ovary syndrome	0.000469	0.0112	CbGeAlD
Losartan—Rhinitis—Metformin—polycystic ovary syndrome	0.000463	0.0165	CcSEcCtD
Losartan—Hepatitis—Metformin—polycystic ovary syndrome	0.000462	0.0164	CcSEcCtD
Losartan—ACE—endometrium—polycystic ovary syndrome	0.000462	0.011	CbGeAlD
Losartan—Hypoaesthesia—Metformin—polycystic ovary syndrome	0.00046	0.0164	CcSEcCtD
Losartan—AGTR1—endocrine gland—polycystic ovary syndrome	0.000439	0.0105	CbGeAlD
Losartan—Flushing—Metformin—polycystic ovary syndrome	0.000429	0.0153	CcSEcCtD
Losartan—Angiopathy—Metformin—polycystic ovary syndrome	0.000419	0.0149	CcSEcCtD
Losartan—SLCO1B1—endocrine gland—polycystic ovary syndrome	0.000418	0.00997	CbGeAlD
Losartan—ACE—pituitary gland—polycystic ovary syndrome	0.000418	0.00997	CbGeAlD
Losartan—ACE—adipose tissue—polycystic ovary syndrome	0.000416	0.00993	CbGeAlD
Losartan—Erythema—Metformin—polycystic ovary syndrome	0.000402	0.0143	CcSEcCtD
Losartan—Flatulence—Metformin—polycystic ovary syndrome	0.000396	0.0141	CcSEcCtD
Losartan—Dysgeusia—Metformin—polycystic ovary syndrome	0.000394	0.014	CcSEcCtD
Losartan—ALB—adrenal gland—polycystic ovary syndrome	0.00039	0.0093	CbGeAlD
Losartan—Muscle spasms—Metformin—polycystic ovary syndrome	0.000387	0.0138	CcSEcCtD
Losartan—Vision blurred—Metformin—polycystic ovary syndrome	0.000379	0.0135	CcSEcCtD
Losartan—Tremor—Metformin—polycystic ovary syndrome	0.000377	0.0134	CcSEcCtD
Losartan—ACE—adrenal gland—polycystic ovary syndrome	0.000374	0.00891	CbGeAlD
Losartan—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000373	0.0133	CcSEcCtD
Losartan—Telmisartan—PPARG—polycystic ovary syndrome	0.000364	1	CrCbGaD
Losartan—Malaise—Metformin—polycystic ovary syndrome	0.000363	0.0129	CcSEcCtD
Losartan—Syncope—Metformin—polycystic ovary syndrome	0.000361	0.0128	CcSEcCtD
Losartan—Palpitations—Metformin—polycystic ovary syndrome	0.000355	0.0127	CcSEcCtD
Losartan—Loss of consciousness—Metformin—polycystic ovary syndrome	0.000354	0.0126	CcSEcCtD
Losartan—ACE—female gonad—polycystic ovary syndrome	0.000348	0.0083	CbGeAlD
Losartan—Myalgia—Metformin—polycystic ovary syndrome	0.000342	0.0122	CcSEcCtD
Losartan—Chest pain—Metformin—polycystic ovary syndrome	0.000342	0.0122	CcSEcCtD
Losartan—CYP2C8—endometrium—polycystic ovary syndrome	0.000339	0.00809	CbGeAlD
Losartan—Discomfort—Metformin—polycystic ovary syndrome	0.000338	0.012	CcSEcCtD
Losartan—Oedema—Metformin—polycystic ovary syndrome	0.000328	0.0117	CcSEcCtD
Losartan—Infection—Metformin—polycystic ovary syndrome	0.000326	0.0116	CcSEcCtD
Losartan—ACE—endocrine gland—polycystic ovary syndrome	0.000324	0.00772	CbGeAlD
Losartan—Shock—Metformin—polycystic ovary syndrome	0.000323	0.0115	CcSEcCtD
Losartan—Nervous system disorder—Metformin—polycystic ovary syndrome	0.000322	0.0115	CcSEcCtD
Losartan—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000321	0.0114	CcSEcCtD
Losartan—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000317	0.0113	CcSEcCtD
Losartan—Anorexia—Metformin—polycystic ovary syndrome	0.000313	0.0111	CcSEcCtD
Losartan—CYP2C8—pituitary gland—polycystic ovary syndrome	0.000307	0.00732	CbGeAlD
Losartan—Hypotension—Metformin—polycystic ovary syndrome	0.000307	0.0109	CcSEcCtD
Losartan—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.000299	0.0106	CcSEcCtD
Losartan—Paraesthesia—Metformin—polycystic ovary syndrome	0.000295	0.0105	CcSEcCtD
Losartan—Dyspnoea—Metformin—polycystic ovary syndrome	0.000293	0.0104	CcSEcCtD
Losartan—Somnolence—Metformin—polycystic ovary syndrome	0.000292	0.0104	CcSEcCtD
Losartan—CYP2C19—vagina—polycystic ovary syndrome	0.000291	0.00694	CbGeAlD
Losartan—Dyspepsia—Metformin—polycystic ovary syndrome	0.000289	0.0103	CcSEcCtD
Losartan—Decreased appetite—Metformin—polycystic ovary syndrome	0.000285	0.0102	CcSEcCtD
Losartan—Fatigue—Metformin—polycystic ovary syndrome	0.000283	0.0101	CcSEcCtD
Losartan—Constipation—Metformin—polycystic ovary syndrome	0.000281	0.00999	CcSEcCtD
Losartan—CYP3A5—adipose tissue—polycystic ovary syndrome	0.000276	0.00658	CbGeAlD
Losartan—CYP2C19—endocrine gland—polycystic ovary syndrome	0.000272	0.0065	CbGeAlD
Losartan—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000271	0.00963	CcSEcCtD
Losartan—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000268	0.00955	CcSEcCtD
Losartan—Urticaria—Metformin—polycystic ovary syndrome	0.000261	0.00928	CcSEcCtD
Losartan—Abdominal pain—Metformin—polycystic ovary syndrome	0.00026	0.00924	CcSEcCtD
Losartan—CYP2C8—vagina—polycystic ovary syndrome	0.000254	0.00606	CbGeAlD
Losartan—CYP2C8—endocrine gland—polycystic ovary syndrome	0.000238	0.00567	CbGeAlD
Losartan—Asthenia—Metformin—polycystic ovary syndrome	0.000236	0.00838	CcSEcCtD
Losartan—Pruritus—Metformin—polycystic ovary syndrome	0.000232	0.00827	CcSEcCtD
Losartan—CYP3A5—female gonad—polycystic ovary syndrome	0.000231	0.0055	CbGeAlD
Losartan—CYP3A5—vagina—polycystic ovary syndrome	0.000229	0.00547	CbGeAlD
Losartan—Diarrhoea—Metformin—polycystic ovary syndrome	0.000225	0.00799	CcSEcCtD
Losartan—CYP1A2—endocrine gland—polycystic ovary syndrome	0.000223	0.00531	CbGeAlD
Losartan—ABCB1—embryo—polycystic ovary syndrome	0.000222	0.0053	CbGeAlD
Losartan—Dizziness—Metformin—polycystic ovary syndrome	0.000217	0.00773	CcSEcCtD
Losartan—CYP3A5—endocrine gland—polycystic ovary syndrome	0.000215	0.00512	CbGeAlD
Losartan—CYP2C9—endocrine gland—polycystic ovary syndrome	0.000211	0.00504	CbGeAlD
Losartan—Vomiting—Metformin—polycystic ovary syndrome	0.000209	0.00743	CcSEcCtD
Losartan—Rash—Metformin—polycystic ovary syndrome	0.000207	0.00737	CcSEcCtD
Losartan—Dermatitis—Metformin—polycystic ovary syndrome	0.000207	0.00736	CcSEcCtD
Losartan—Headache—Metformin—polycystic ovary syndrome	0.000206	0.00732	CcSEcCtD
Losartan—Nausea—Metformin—polycystic ovary syndrome	0.000195	0.00694	CcSEcCtD
Losartan—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000182	0.00434	CbGeAlD
Losartan—ABCB1—endometrium—polycystic ovary syndrome	0.000163	0.00388	CbGeAlD
Losartan—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000161	0.00384	CbGeAlD
Losartan—ABCB1—uterus—polycystic ovary syndrome	0.00015	0.00357	CbGeAlD
Losartan—ABCB1—pituitary gland—polycystic ovary syndrome	0.000147	0.00351	CbGeAlD
Losartan—ABCB1—adipose tissue—polycystic ovary syndrome	0.000147	0.0035	CbGeAlD
Losartan—ABCB1—adrenal gland—polycystic ovary syndrome	0.000131	0.00314	CbGeAlD
Losartan—ABCB1—female gonad—polycystic ovary syndrome	0.000123	0.00292	CbGeAlD
Losartan—ABCB1—vagina—polycystic ovary syndrome	0.000122	0.00291	CbGeAlD
Losartan—ABCB1—endocrine gland—polycystic ovary syndrome	0.000114	0.00272	CbGeAlD
Losartan—CYP3A5—Metabolism—AKR1C1—polycystic ovary syndrome	7.41e-06	0.000113	CbGpPWpGaD
Losartan—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	7.39e-06	0.000113	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.35e-06	0.000113	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—TH—polycystic ovary syndrome	7.32e-06	0.000112	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—CYP19A1—polycystic ovary syndrome	7.31e-06	0.000112	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	7.3e-06	0.000112	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	7.29e-06	0.000112	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	7.28e-06	0.000112	CbGpPWpGaD
Losartan—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	7.26e-06	0.000111	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—CYP1A1—polycystic ovary syndrome	7.25e-06	0.000111	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—SLC2A4—polycystic ovary syndrome	7.12e-06	0.000109	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—STAR—polycystic ovary syndrome	7.11e-06	0.000109	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	7.03e-06	0.000108	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.96e-06	0.000107	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	6.95e-06	0.000107	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.92e-06	0.000106	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	6.91e-06	0.000106	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IRS2—polycystic ovary syndrome	6.83e-06	0.000105	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—SULT2A1—polycystic ovary syndrome	6.82e-06	0.000104	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	6.81e-06	0.000104	CbGpPWpGaD
Losartan—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	6.79e-06	0.000104	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—LHB—polycystic ovary syndrome	6.78e-06	0.000104	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—MTHFR—polycystic ovary syndrome	6.76e-06	0.000104	CbGpPWpGaD
Losartan—ALB—Metabolism—LHB—polycystic ovary syndrome	6.74e-06	0.000103	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PNPLA2—polycystic ovary syndrome	6.72e-06	0.000103	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CYP19A1—polycystic ovary syndrome	6.7e-06	0.000103	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—LEP—polycystic ovary syndrome	6.68e-06	0.000102	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	6.63e-06	0.000102	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—HSD3B2—polycystic ovary syndrome	6.62e-06	0.000101	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—RRM2—polycystic ovary syndrome	6.6e-06	0.000101	CbGpPWpGaD
Losartan—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	6.59e-06	0.000101	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	6.56e-06	0.0001	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—GNAS—polycystic ovary syndrome	6.52e-06	9.99e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	6.47e-06	9.92e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—PPARG—polycystic ovary syndrome	6.44e-06	9.87e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AKR1C1—polycystic ovary syndrome	6.42e-06	9.83e-05	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	6.39e-06	9.79e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	6.38e-06	9.77e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SRD5A1—polycystic ovary syndrome	6.37e-06	9.76e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—YAP1—polycystic ovary syndrome	6.36e-06	9.75e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—POMC—polycystic ovary syndrome	6.36e-06	9.74e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—HMMR—polycystic ovary syndrome	6.34e-06	9.71e-05	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—INS—polycystic ovary syndrome	6.32e-06	9.68e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	6.22e-06	9.52e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—NCOR1—polycystic ovary syndrome	6.21e-06	9.52e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	6.19e-06	9.48e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	6.19e-06	9.48e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—NAMPT—polycystic ovary syndrome	6.11e-06	9.37e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—STAR—polycystic ovary syndrome	6.08e-06	9.31e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—PPARG—polycystic ovary syndrome	6.07e-06	9.3e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	6.05e-06	9.27e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—HSD3B1—polycystic ovary syndrome	6.05e-06	9.27e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CYP11A1—polycystic ovary syndrome	6.04e-06	9.25e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	6.01e-06	9.21e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—POMC—polycystic ovary syndrome	5.99e-06	9.18e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	5.98e-06	9.16e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—GNAS—polycystic ovary syndrome	5.98e-06	9.16e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IRS1—polycystic ovary syndrome	5.96e-06	9.13e-05	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—INS—polycystic ovary syndrome	5.96e-06	9.12e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	5.91e-06	9.06e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—LHB—polycystic ovary syndrome	5.9e-06	9.05e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—SULT2A1—polycystic ovary syndrome	5.9e-06	9.04e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—CYP1A1—polycystic ovary syndrome	5.89e-06	9.02e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	5.87e-06	8.99e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	5.77e-06	8.84e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—POMC—polycystic ovary syndrome	5.74e-06	8.79e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	5.73e-06	8.77e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—RRM2—polycystic ovary syndrome	5.72e-06	8.76e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—INS—polycystic ovary syndrome	5.71e-06	8.74e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—AKR1C3—polycystic ovary syndrome	5.7e-06	8.74e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—NCOR1—polycystic ovary syndrome	5.69e-06	8.72e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—RRM2—polycystic ovary syndrome	5.69e-06	8.71e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	5.67e-06	8.68e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CYP17A1—polycystic ovary syndrome	5.61e-06	8.6e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	5.59e-06	8.56e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IGF1—polycystic ovary syndrome	5.52e-06	8.46e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—AKT2—polycystic ovary syndrome	5.52e-06	8.45e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—LHB—polycystic ovary syndrome	5.52e-06	8.45e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—YAP1—polycystic ovary syndrome	5.51e-06	8.44e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—MTHFR—polycystic ovary syndrome	5.49e-06	8.41e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—YAP1—polycystic ovary syndrome	5.48e-06	8.4e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—PPARG—polycystic ovary syndrome	5.48e-06	8.39e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—IGF1—polycystic ovary syndrome	5.45e-06	8.36e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—AKT2—polycystic ovary syndrome	5.45e-06	8.35e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—HMMR—polycystic ovary syndrome	5.42e-06	8.3e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—POMC—polycystic ovary syndrome	5.4e-06	8.28e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—CYP1A1—polycystic ovary syndrome	5.4e-06	8.27e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—HSD3B2—polycystic ovary syndrome	5.39e-06	8.26e-05	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—INS—polycystic ovary syndrome	5.37e-06	8.23e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—NAMPT—polycystic ovary syndrome	5.3e-06	8.11e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	5.27e-06	8.07e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—NAMPT—polycystic ovary syndrome	5.27e-06	8.07e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.26e-06	8.07e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—SERPINE1—polycystic ovary syndrome	5.24e-06	8.03e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	5.23e-06	8.02e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYP11A1—polycystic ovary syndrome	5.23e-06	8.01e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AKR1C1—polycystic ovary syndrome	5.22e-06	8e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	5.2e-06	7.97e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.19e-06	7.95e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	5.19e-06	7.95e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	5.18e-06	7.94e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—HSD3B1—polycystic ovary syndrome	5.17e-06	7.92e-05	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	5.16e-06	7.91e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	5.14e-06	7.88e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	5.11e-06	7.83e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	5.1e-06	7.82e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—MTHFR—polycystic ovary syndrome	5.03e-06	7.71e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	4.98e-06	7.63e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AKR1C3—polycystic ovary syndrome	4.94e-06	7.57e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	4.92e-06	7.54e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	4.92e-06	7.53e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	4.91e-06	7.52e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYP17A1—polycystic ovary syndrome	4.86e-06	7.45e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—TH—polycystic ovary syndrome	4.86e-06	7.44e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	4.84e-06	7.42e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	4.83e-06	7.41e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SULT2A1—polycystic ovary syndrome	4.81e-06	7.36e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	4.8e-06	7.36e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	4.73e-06	7.24e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—SLC2A4—polycystic ovary syndrome	4.72e-06	7.24e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—LHB—polycystic ovary syndrome	4.71e-06	7.22e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.7e-06	7.2e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	4.69e-06	7.19e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	4.67e-06	7.15e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—RRM2—polycystic ovary syndrome	4.65e-06	7.13e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.63e-06	7.1e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	4.61e-06	7.07e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—HSD3B2—polycystic ovary syndrome	4.61e-06	7.06e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	4.56e-06	6.98e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—YAP1—polycystic ovary syndrome	4.49e-06	6.87e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AKR1C1—polycystic ovary syndrome	4.46e-06	6.84e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PPARG—polycystic ovary syndrome	4.45e-06	6.82e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CYP19A1—polycystic ovary syndrome	4.44e-06	6.81e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	4.41e-06	6.75e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—POMC—polycystic ovary syndrome	4.39e-06	6.73e-05	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—INS—polycystic ovary syndrome	4.37e-06	6.69e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	4.34e-06	6.65e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—NAMPT—polycystic ovary syndrome	4.31e-06	6.6e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	4.3e-06	6.59e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	4.28e-06	6.56e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP11A1—polycystic ovary syndrome	4.26e-06	6.52e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	4.24e-06	6.49e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	4.23e-06	6.47e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—IL6—polycystic ovary syndrome	4.22e-06	6.47e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—TH—polycystic ovary syndrome	4.21e-06	6.44e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—TH—polycystic ovary syndrome	4.18e-06	6.41e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	4.18e-06	6.41e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SULT2A1—polycystic ovary syndrome	4.11e-06	6.29e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—SLC2A4—polycystic ovary syndrome	4.09e-06	6.27e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PPARG—polycystic ovary syndrome	4.08e-06	6.25e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	4.07e-06	6.23e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—POMC—polycystic ovary syndrome	4.02e-06	6.16e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AKR1C3—polycystic ovary syndrome	4.02e-06	6.16e-05	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—INS—polycystic ovary syndrome	4e-06	6.13e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	3.99e-06	6.11e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—RRM2—polycystic ovary syndrome	3.98e-06	6.09e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GNAS—polycystic ovary syndrome	3.96e-06	6.07e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP17A1—polycystic ovary syndrome	3.96e-06	6.06e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYP19A1—polycystic ovary syndrome	3.85e-06	5.89e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—YAP1—polycystic ovary syndrome	3.83e-06	5.87e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	3.83e-06	5.86e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—NCOR1—polycystic ovary syndrome	3.78e-06	5.79e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—TH—polycystic ovary syndrome	3.75e-06	5.75e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—NAMPT—polycystic ovary syndrome	3.68e-06	5.64e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—TH—polycystic ovary syndrome	3.66e-06	5.61e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	3.66e-06	5.61e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	3.65e-06	5.6e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	3.64e-06	5.57e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP11A1—polycystic ovary syndrome	3.64e-06	5.57e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	3.61e-06	5.53e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—VEGFA—polycystic ovary syndrome	3.61e-06	5.52e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—CYP1A1—polycystic ovary syndrome	3.58e-06	5.49e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	3.57e-06	5.46e-05	CbGpPWpGaD
Losartan—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	3.56e-06	5.46e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	3.56e-06	5.45e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	3.44e-06	5.28e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AKR1C3—polycystic ovary syndrome	3.43e-06	5.26e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	3.43e-06	5.26e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GNAS—polycystic ovary syndrome	3.43e-06	5.26e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—TH—polycystic ovary syndrome	3.42e-06	5.25e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—GNAS—polycystic ovary syndrome	3.41e-06	5.23e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP17A1—polycystic ovary syndrome	3.38e-06	5.18e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	3.35e-06	5.14e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—MTHFR—polycystic ovary syndrome	3.34e-06	5.11e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SLC2A4—polycystic ovary syndrome	3.33e-06	5.1e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—NCOR1—polycystic ovary syndrome	3.27e-06	5.01e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—NCOR1—polycystic ovary syndrome	3.25e-06	4.98e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	3.17e-06	4.85e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP19A1—polycystic ovary syndrome	3.13e-06	4.8e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—CYP1A1—polycystic ovary syndrome	3.1e-06	4.75e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	3.08e-06	4.72e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	3.07e-06	4.7e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	3.07e-06	4.7e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	2.99e-06	4.58e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	2.96e-06	4.53e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—TH—polycystic ovary syndrome	2.93e-06	4.48e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	2.92e-06	4.47e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—MTHFR—polycystic ovary syndrome	2.89e-06	4.43e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—MTHFR—polycystic ovary syndrome	2.87e-06	4.4e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	2.85e-06	4.37e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SLC2A4—polycystic ovary syndrome	2.85e-06	4.36e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	2.84e-06	4.35e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	2.81e-06	4.3e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GNAS—polycystic ovary syndrome	2.8e-06	4.28e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	2.77e-06	4.24e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PPARG—polycystic ovary syndrome	2.71e-06	4.15e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	2.7e-06	4.14e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP19A1—polycystic ovary syndrome	2.68e-06	4.1e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—POMC—polycystic ovary syndrome	2.67e-06	4.09e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—NCOR1—polycystic ovary syndrome	2.66e-06	4.08e-05	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—INS—polycystic ovary syndrome	2.65e-06	4.07e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	2.65e-06	4.06e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	2.61e-06	4e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	2.58e-06	3.95e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—CYP1A1—polycystic ovary syndrome	2.52e-06	3.87e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	2.52e-06	3.86e-05	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—IL6—polycystic ovary syndrome	2.49e-06	3.82e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GNAS—polycystic ovary syndrome	2.39e-06	3.66e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—MTHFR—polycystic ovary syndrome	2.35e-06	3.61e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PPARG—polycystic ovary syndrome	2.34e-06	3.59e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—PPARG—polycystic ovary syndrome	2.33e-06	3.57e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—POMC—polycystic ovary syndrome	2.31e-06	3.54e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—INS—polycystic ovary syndrome	2.3e-06	3.52e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—POMC—polycystic ovary syndrome	2.3e-06	3.52e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—INS—polycystic ovary syndrome	2.29e-06	3.5e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—NCOR1—polycystic ovary syndrome	2.28e-06	3.49e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—TH—polycystic ovary syndrome	2.26e-06	3.46e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	2.2e-06	3.37e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—CYP1A1—polycystic ovary syndrome	2.16e-06	3.3e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	2.09e-06	3.21e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	2.07e-06	3.16e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	2.06e-06	3.16e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—INS—polycystic ovary syndrome	2.05e-06	3.14e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	2.04e-06	3.13e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—POMC—polycystic ovary syndrome	2.01e-06	3.09e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—MTHFR—polycystic ovary syndrome	2.01e-06	3.08e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—INS—polycystic ovary syndrome	2e-06	3.07e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PPARG—polycystic ovary syndrome	1.91e-06	2.92e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—POMC—polycystic ovary syndrome	1.88e-06	2.88e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—INS—polycystic ovary syndrome	1.87e-06	2.87e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	1.84e-06	2.82e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	1.76e-06	2.69e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	1.66e-06	2.55e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PPARG—polycystic ovary syndrome	1.63e-06	2.5e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—POMC—polycystic ovary syndrome	1.61e-06	2.46e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—INS—polycystic ovary syndrome	1.6e-06	2.45e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	1.55e-06	2.38e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	1.26e-06	1.93e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	1.24e-06	1.9e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—INS—polycystic ovary syndrome	1.23e-06	1.89e-05	CbGpPWpGaD
